Prof. AYTUĞ ÜNER

Publication Network

Articles 88

1. Incidence and Patterns of Second Primary Malignancies in Genitourinary Cancer Survivors: A 20-Year Single-Center Experience

Eroglu I., Avsar H., sutcuoglu o., tahtaci g., Gürler F., Coskun U., et al.

Journal of oncological sciences , vol.12, no.1, pp.41-50, 2026 (Scopus, TRDizin)

2. Clinicopathological Characteristics of Metastatic Colorectal Cancer Patients with Prolonged Survival

EROĞLU İ., SÜTCÜOĞLU O., SAVAŞ G., GÜRLER F., COŞKUN U., ÜNER A., et al.

Journal of oncological sciences , vol.11, pp.244-252, 2025 (Scopus, TRDizin)

3. Evaluation of 30-day mortality rate following intravenous systemic anticancer therapy: a retrospective analysis

ÇETİN T. E., SÜTCÜOĞLU O., AKDOĞAN O., SAVAŞ G., Günel N., ÜNER A., et al.

BMC Cancer , vol.25, no.1, 2025 (SCI-Expanded, Scopus)

4. Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial

AKDOĞAN O., Uyar G. C., Yesilbas E., Baskurt K., MALKOÇ N. A., ÖZDEMİR N., et al.

EUROPEAN JOURNAL OF CANCER , vol.221, 2025 (SCI-Expanded, Scopus)

5. Carcinoma erysipeloides, a case-report and review of the sixty-nine cases in the literature

EROĞLU İ., ÜNER A., GÜRLER F., YAZICI O., ÖZET A., ÖZDEMİR N.

American Journal of the Medical Sciences , vol.369, no.4, pp.485-490, 2025 (SCI-Expanded, Scopus)

6. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

YAŞAR H. A., Aktas B. Y., Ucar G., SEZGİN GÖKSU S., Bilgetekin I., Cakar B., et al.

Clinical Genitourinary Cancer , vol.22, no.3, 2024 (SCI-Expanded, Scopus)

7. The frequency of autoimmune disease in the first degree and other relatives of the breast cancer patients Meme kanserli hastaların birinci derece ve diğer yakınlarındaki otoimmün hastalık sıklığı

Atay A., GÖKER B., ÖZTÜRK M. A., TUFAN A., HAZNEDAROĞLU Ş., Babaoğlu H., et al.

Journal of Turkish Society For Rheumatology , vol.16, no.1, pp.32-37, 2024 (Scopus, TRDizin)

8. Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy.

BİR YÜCEL K., Kilic A. C., SÜTCÜOĞLU O., YAZICI O., Kilic K., SAVAŞ G., et al.

Journal of chemotherapy (Florence, Italy) , vol.36, no.3, pp.249-257, 2024 (SCI-Expanded, Scopus)

9. The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

ASLAN V., KARABÖRK KILIÇ A. C., ÖZET A., ÜNER A., GÜNEL N., YAZICI O., et al.

BMC Cancer , vol.23, no.1, 2023 (SCI-Expanded, Scopus)

10. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment

BİR YÜCEL K., SÜTCÜOĞLU O., YAZICI O., YILDIZ Y., ŞENOL E., ÜNER A.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.29, no.3, pp.760-763, 2023 (SCI-Expanded, Scopus)

11. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

SÜTCÜOĞLU O., Doğan A., Yilmaz F., Şahin A. B., Şahin T. K., Esen S. A., et al.

Pancreas , vol.52, no.4, 2023 (SCI-Expanded, Scopus)

12. Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Yücel K. B., Özay Z. I., SÜTCÜOĞLU O., YAZICI O., ÜNER A., GÜNEL N., et al.

Supportive Care in Cancer , vol.31, no.2, 2023 (SCI-Expanded, Scopus) Sustainable Development

13. Association of Immunoscore, CD73 Expression and 53BP1 Expression with Neoadjuvant Chemoradiotherapy Efficacy in Patients with Locally Advanced Rectal Cancer

Sütcüoğlu O., İnan M. A., Üner A., Savaş G., Bora H., Özet A., et al.

Journal of oncological sciences , vol.9, no.1, pp.23-32, 2023 (Scopus, TRDizin)

14. LAG-3 expression in tumor microenvironment of triple-negative breast cancer

Tahtaci G., Gunel N., Sadioglu A., AKYÜREK N., Boz O., ÜNER A.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.53, no.1, pp.142-148, 2023 (SCI-Expanded, Scopus, TRDizin)

15. ROAR trial: which treatment is effective after progression?

SÜTCÜOĞLU O., Yücel K., ÜNER A., YAZICI O., ÖZDEMİR N.

LANCET ONCOLOGY , vol.23, no.3, 2022 (SCI-Expanded, Scopus)

16. Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

ÜNSAL O., YAZICI O., ÖZDEMİR N., ÇUBUKÇU E., OCAK B., ÜNER A., et al.

FUTURE ONCOLOGY , vol.18, no.5, pp.533-541, 2022 (SCI-Expanded, Scopus) Sustainable Development

17. Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies

Cavusoglu C., TAHTACI G., Dogrul R. T., Ileri I., Yildirim F., Candemir B., et al.

BMC GERIATRICS , vol.21, no.1, 2021 (SCI-Expanded, SSCI, Scopus) Sustainable Development

18. Respiratory-gated FDG PET/MRI in Evaluation of Primary Gastric Lesions and Gastric Lymph Nodes in Patients with Gastric Cancer

Ates S. G., AYDOS U., AKDEMİR Ü. Ö., YÜKSEL O., ÜNER A., DURSUN A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.48, no.SUPPL 1, 2021 (SCI-Expanded, Scopus) Sustainable Development

19. Expression of CD10, BCL-6 and MUM-1 Markers and Their Effects on Prognosis in Diffuse Large B Cell Lymphoma

YOZGAT A., KASAPOĞLU B., AKYÜREK N., ÜNER A.

ACTA ONCOLOGICA TURCICA , vol.54, no.2, pp.189-197, 2021 (Peer-Reviewed Journal)

20. Ezrin is a prognostic biomarker in patients with clear cell metastatic renal cell carcinoma receiving sunitinib

ÇETİN B., IŞIK GÖNÜL İ., GÜMÜŞAY Ö., AFŞAR B., Bilgetekin I., ÖZET A., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.17, no.2, pp.408-413, 2021 (SCI-Expanded, Scopus)

21. Is there any relationship between Helicobacter pylori infection and human epidermal growth factor receptor 2 expression in gastric cancer?

Algin E., Baykara M., Yilmaz G., Cetin B., EKİNCİ Ö., ÜNER A., et al.

Journal of Cancer Research and Therapeutics , vol.16, no.8, 2020 (SCI-Expanded, Scopus)

22. Ewing's sarcoma of kidney in a 60-year-old patient with local recurrence: A rare occurrence

Bilgetekin I., Karaca M., IŞIK GÖNÜL İ., ÜNER A., Sahinli H., Demir H., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.6, pp.1422-1424, 2018 (SCI-Expanded, Scopus) Sustainable Development

23. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme

Cetin B., IŞIK GÖNÜL İ., GÜMÜŞAY Ö., Bilgetekin I., Algin E., ÖZET A., et al.

NEUROPATHOLOGY , vol.38, no.5, pp.457-462, 2018 (SCI-Expanded, Scopus) Sustainable Development

24. Pazopanib-Induced Hepatotoxicity in an Experimental Rat Model

Cetin B., Yilmaz G. E., Armagan B., Afşar B., Demirci U., Gülbahar Ö., et al.

CHEMOTHERAPY , vol.63, no.1, pp.39-45, 2018 (SCI-Expanded, Scopus)

25. Prognostic Value of Mean Platelet Volume in Glioblastoma Multiforme

TAHTACI G., GÜNEL N., ÜNER A., TAHTACI M.

GAZI MEDICAL JOURNAL , vol.29, no.4, pp.336-339, 2018 (ESCI, Scopus, TRDizin)

26. The assessment of incidental thyroid lesions on 18F-fluorodeoxyglucose positron emission tomography/computed tomogrophy: A single centre experience

ALGIN E., ÜNER A., AKDEMİR Ü. Ö., GÜMÜŞAY Ö., KAPUCU Ö., ÖZET A.

Journal of Oncological Sciences , vol.3, no.2, pp.57-61, 2017 (TRDizin)

27. Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients

GÜMÜŞAY Ö., Cetin B., Benekli M., Gurcan G., İLHAN M. N., Bostankolu B., et al.

JOURNAL OF CANCER EDUCATION , vol.31, no.2, pp.308-313, 2016 (SCI-Expanded, Scopus) Sustainable Development

28. Crizotinib-induced toxicity in an experimental rat model

Gümüşay Ö., Esendagli-Yilmaz G., Üner A., Çetin B., Buyukberber S., Benekli M., et al.

WIENER KLINISCHE WOCHENSCHRIFT , vol.128, pp.435-441, 2016 (SCI-Expanded, Scopus)

29. Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., et al.

JOURNAL OF GASTROINTESTINAL SURGERY , vol.19, no.9, pp.1565-1571, 2015 (SCI-Expanded, Scopus) Sustainable Development

30. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

TURAN N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , vol.27, no.4, pp.408-416, 2015 (SCI-Expanded, Scopus)

31. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

Gumusay O., Benekli M., EKİNCİ Ö., Baykara M., ÖZET A., Coskun U., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.45, no.5, pp.416-421, 2015 (SCI-Expanded, Scopus)

32. Factors predicting the development of distant metastases in patients with head and neck squamous cell carcinoma: A retrospective study from a single centre

Gumusay O., ÖZET A., Buyukberber S., Baykara M., Coskun U., Cetin B., et al.

JOURNAL OF BUON , vol.20, no.2, pp.521-526, 2015 (SCI-Expanded, Scopus) Sustainable Development

33. Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin

Algin E., ÖZET A., Gumusay O., Cetin B., AKDEMİR Ü. Ö., Benekli M., et al.

ANNALS OF NUCLEAR MEDICINE , vol.28, no.9, pp.891-896, 2014 (SCI-Expanded, Scopus)

34. Factors predicting recurrence in patients with grade III glial tumors: Impact of adjuvant temozolomide on recurrence

Gumusay O., Cetin B., Ozet A., Demirci U., Buyukberber S., Coskun U., et al.

JOURNAL OF BUON , vol.19, no.4, pp.1035-1040, 2014 (SCI-Expanded, Scopus)

35. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

Turan N., Benekli M., Dane F., Unal O. U., Kara H. V., Koca D., et al.

THORACIC CANCER , vol.5, no.5, pp.398-404, 2014 (SCI-Expanded, Scopus) Sustainable Development

36. Combination of Cyclophosphamide and Carboplatin in Recurrent Malignant Gliomas

Demirci U., Buyukberber S., Ozdemir N., Coskun U., Karaca H., AKMANSU M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.23, no.3, pp.178-183, 2013 (SCI-Expanded, Scopus, TRDizin)

37. Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

Turan N., Benekli M., Koca D., Ustaalioglu B. O., Dane F., Ozdemir N., et al.

ONCOLOGY , vol.84, no.1, pp.14-21, 2013 (SCI-Expanded, Scopus) Sustainable Development

38. Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer

Tonyali O., Coskun U., Sener N., İNANÇ M., Akman T., Oksuzoglu B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.138, no.12, pp.2145-2151, 2012 (SCI-Expanded, Scopus) Sustainable Development

39. Hepatotoxicity associated with lapatinib in an experimental rat model

Demirci U., Buyukberber S., Yilmaz G., KEREM M., Coskun U., ÜNER A., et al.

EUROPEAN JOURNAL OF CANCER , vol.48, no.2, pp.279-285, 2012 (SCI-Expanded, Scopus)

40. The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer

YILDIZ R., Benekli M., Buyukberber S., Kaya A. O., Ozturk B., Yaman E., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.136, no.10, pp.1471-1476, 2010 (SCI-Expanded, Scopus) Sustainable Development

41. Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer

Kaya A. O., Buyukberber S., Benekli M., Coskun U., Sevinc A., AKMANSU M., et al.

MEDICAL ONCOLOGY , vol.27, no.1, pp.152-157, 2010 (SCI-Expanded, Scopus) Sustainable Development

42. Bevacizumab Plus Irinotecan-Based Therapy in Metastatic Colorectal Cancer Patients Previously Treated With Oxaliplatin-Based Regimens

YILDIZ R., Buyukberber S., ÜNER A., Yamac D., Coskun U., Kaya A. O., et al.

CANCER INVESTIGATION , vol.28, no.1, pp.33-37, 2010 (SCI-Expanded, Scopus) Sustainable Development

43. Gemcitabine Combined With Uracil-Tegafur in Patients With Advanced Pancreatic Cancer

Coskun U., Alkis N., Celenkoglu G., Buyukberber S., ÖZKAN M., Camci C., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , vol.101, no.8, pp.761-764, 2009 (SCI-Expanded, Scopus) Sustainable Development

44. Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

Acar A., Onan A., Coskun U., ÜNER A., BAĞRIAÇIK E. Ü., Atalay F., et al.

MEDICAL ONCOLOGY , no.3, pp.279-283, 2008 (SCI-Expanded, Scopus) Sustainable Development

45. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas

Yaman E., Buyukberber S., ÜNER A., Coskun U., Yamac D., Ozturk B., et al.

TUMORI J , vol.94, no.5, pp.674-680, 2008 (SCI-Expanded, Scopus)

46. Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane plus platinum regimens

Coskun U., Kaya A. O., Buyukberber S., Benekli M., ÜNER A., Dikilitas M., et al.

MEDICAL ONCOLOGY , vol.25, no.2, pp.133-136, 2008 (SCI-Expanded, Scopus) Sustainable Development

47. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.

Unsal D., AKYÜREK N., ÜNER A., Erpolat P., Han U., AKMANSU M., et al.

American journal of clinical oncology , vol.31, no.1, pp.55-63, 2008 (SCI-Expanded, Scopus) Sustainable Development

48. Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: Radiologic and pathologic imaging

ÜNER A., Ozturk B., Benekli M., Coskun U., Kocak S., Kaya A. O., et al.

BREAST JOURNAL , vol.14, no.1, pp.109-110, 2008 (SCI-Expanded, Scopus)

49. Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin

Kaya A. O., Coskun U., ÜNLÜ M., AKDEMİR Ü. Ö., ÖZDEMİR N., Zengin N., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.9, no.4, pp.683-686, 2008 (SCI-Expanded, Scopus) Sustainable Development

50. The role of 18F-FDG PET/CT in follow up of advanced stage breast cancer

Can N., Kapucu O., ÜNER A., ÜNLÜ M.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.18, no.1, pp.9-15, 2008 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

51. Synchronous squamous cell lung carcinoma and rectum adenocarcinoma: Case report

Kaya A. O., YILDIZ R., Oeztuerk B., Yaman E., Barit G., Coskun U., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.18, no.1, pp.42-45, 2008 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

52. Temozolomide in newly diagnosed malignant gliomas: Administered concomitantly with radiotherapy, and thereafter as consolidation treatment

Yaman E., Buyukberber S., ÜNER A., Coskun U., AKMANSU M., Benekli M., et al.

ONKOLOGIE , vol.31, no.6, pp.309-313, 2008 (SCI-Expanded, Scopus)

53. Kolorektal kanserlerin tedavi sonuçları: tek merkezli, 200 vakalık seri

Menteş B. B., Ege B., ÜNER A., Ünsal D., YÜKSEL O., BOSTANCI H., et al.

Gazi Medical Journal , vol.18, no.3, pp.97-103, 2007 (Scopus, TRDizin) Sustainable Development

54. Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes

Benekli M., YILDIZ R., ÜNER A., Er O., Yamac D., Alkis N., et al.

ONCOLOGY , vol.72, pp.308-313, 2007 (SCI-Expanded, Scopus) Sustainable Development

55. Aggressive tricholemmal carcinoma of the axilla

Demirtaş Y., Findikçioǧlu F., AYHAN M. S., ÖZMEN S., ÜNER A., Şimşek A., et al.

Gazi Medical Journal , vol.16, no.1, pp.51-53, 2005 (Scopus, TRDizin)

56. Pankreas kanserinde radyoterapinin rolü: Retrospektif değerlendirme

UNSAL D., AKMANSU M., BORA H., ÜNER A., ERPOLAT Ö. P., PAK Y.

Turkiye Klinikleri Tip Bilimleri Dergisi , 2004 (TRDizin) Sustainable Development

57. A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study

Yalcin B., ÜNER A., AKBULUT H., İÇLİ F., Buyukcelik A., Isikdogan A., et al.

ANNALS OF ONCOLOGY , vol.15, pp.42, 2004 (SCI-Expanded, Scopus) Sustainable Development

58. Expression of Vascular Endothelial Growth Factor c-erbB-2 and c-erbB-3 in colorectal tumors

ÜNER A., Ebinc F. A., AKYÜREK N., Unsal D., Mentes B. B., DURSUN A.

ANNALS OF ONCOLOGY , vol.15, pp.74, 2004 (SCI-Expanded, Scopus)

59. THE ROLE OF RADIOTHERAPY IN PANCREATIC CANCER: RETROSPECTIVE EVALUATION

KILIÇ D., AKMANSU M., BORA H., ÜNER A., ERPOLAT Ö. P., Pak Y.

Pankreas Kanserinde Radyoterapinin Rolü: Retrospektif Değerlendirme , 2004 (TRDizin) Sustainable Development

60. Hematoloji-Onkoloji literatüründen seçmeler.

KILIÇ D., ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.5, no.4, pp.228-233, 2003 (SCI-Expanded, Scopus, TRDizin)

61. Akciğer kanserlerinde moleküler onkolojik hedefe yöneltilmiş tedaviler. Solunum.

ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.1, no.5, pp.167-173, 2003 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

62. Metastatik kolorektal kanserde kemoterapi.

ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.5, no.4, pp.201-206, 2003 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

63. Kolorektal kanser aşıları.

BAĞRIAÇIK E. Ü., ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.5, no.4, pp.207-214, 2003 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

64. Erken Evre Meme Kanserinde Tedavi. Adjuvan Radyoterapi Zamanlaması: Kemoterapi Sonrası Yapılabilir.

ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.3, no.2, pp.96-98, 2001 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

65. Detection of metastases in the sentinel lymph nodes of primary breast cancer patients by lymphatic mapping and intraoperative gamma probe: Initial experience

KİTAPÇI M. T., MENTEŞ B., ÜNER A., ABAMOR E., DURSUN A., KAPLAN M., et al.

Turkish Journal of Cancer , vol.31, no.1, pp.27-34, 2001 (TRDizin) Sustainable Development

66. İleri evre akciğer kanserlerinde palyatif kemoterapi. Solunum.

ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.2, no.3, pp.194-200, 2001 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

67. Small cell carcinoma of the prostate: Report of two cases

Sözen S., ÜNER A., Alkibay T.

Turkish Journal of Cancer , vol.30, no.3, pp.131-134, 2000 (Scopus, TRDizin) Sustainable Development

68. Small cell carcinoma of the prostate: Report of two cases

SÖZEN T. S., ÜNER A., ALKİBAY T.

Turkish Journal of Cancer , vol.30, no.3, pp.131-134, 2000 (TRDizin)

69. Vinorelbin.

ÜNER A.

Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi , vol.2, no.1, pp.60-64, 2000 (SCI-Expanded, Scopus, TRDizin)

70. The use of CA15-3 and estrogen receptor in breast cancer patients with bone metastases

KARAKAN T., GÜNEL N., AKÇALI Z., ÜNER A.

GAZI MEDICAL JOURNAL , vol.9, no.4, pp.149-153, 1998 (Scopus) Sustainable Development

71. The Effect of Neoadjuvant Chemotherapy in Gastric Cancer: Report of a Case

TEKİN E., ÖKTEMER S., TANERLİ F., ÜNER A., DURSUN A., DURMUŞ O., et al.

GAZI MEDICAL JOURNAL , vol.9, no.1, pp.44-45, 1998 (Scopus) Sustainable Development

72. A small cell lung carcinoma presenting with eaton-lambert myasthenic syndrome and acanthosis nigricans

GÜNEL N., YAMAÇ D., ÜNER A.

Turkish Journal of Cancer , vol.28, no.3, pp.130-133, 1998 (TRDizin)

73. Tropisetron ve ondansetronun cisplatine bağlı bulantı vekusmayı önleyici etkilerinin karşıklaştırılması.

ÜNER A., GÜNEL N., YAMAÇ D.

Türk Hematoloji Onkoloji Dergisi , vol.8, no.1, pp.23-26, 1998 (TRDizin)

74. Testis Kanseri Kemoterapisinde Yenilikler

ÜNER A.

Aktüel Tıp , vol.3, no.10, pp.545-548, 1998 (Peer-Reviewed Journal) Sustainable Development

75. Pyomyositis in a patient with lymphoma.

ÜNER A., ÇAKIR B., GÜNEL N., AKÇALI Z., YILMAZ M.

Türk Hematoloji Onkoloji Dergisi , vol.7, no.3, pp.169-171, 1997 (Peer-Reviewed Journal)

76. Malign mide ülserlerinin ayırıcı tanısında ülser çevresi dokunun histopatolojik özellikleri ve CA 19-9

DUMLU G. Ş., CİNDORUK M., ÜNAL S., DOĞAN Ü. B., GÖRGÜL A., ÜNER A., et al.

Turkish Journal Of Gastroenterology , vol.8, no.2, pp.197-200, 1997 (Scopus, TRDizin)

77. Retroperitoneal liposarkom olgusu.

TAŞÇI Y., ÜNER A., ÜNER Ç., AKYAR G.

klinik Bilimler Dahiliye , vol.2, no.5, pp.110-112, 1996 (TRDizin)

78. Primer adrenal lenfoması

SEZGİN O., ÜNER A., KARAOĞUZ H.

Klinik Bilimler: Dahiliye , vol.1, no.9, pp.244-246, 1995 (Peer-Reviewed Journal)

79. Periosteal osteosarkom

SAĞLIK Y., ERDEMLİ B. A., ÜNER A., DOĞAN M., MAHMUTYAZICIOĞLU K.

Türk Hematoloji Onkoloji Dergisi , vol.5, no.3, pp.152-157, 1995 (Peer-Reviewed Journal)

80. Results of intensified therapy in acute lymphoblastic leukemia in adults.

DİNÇOL D., İÇLİ F., ÇAY ŞENLER F., KARAOĞUZ H., DEMİRKAZIK A., ÜNER A.

Turkish Journal of Medical Research , vol.12, no.2, pp.57-61, 1994 (Peer-Reviewed Journal)

81. Ferritin.

DEMİRKAZIK A., ÜNER A.

Türk Hematoloji Onkoloji Dergisi , vol.3, no.2, pp.110-112, 1993 (Peer-Reviewed Journal)

82. Evre II-IIIA meme kanserli premenopozal hastalarda adjuvant 6 kür CMF ve 3 kür CMF uygulamalarının karşılaştırmalı sonuçları.

DEMİRKAZIK A., İÇLİ F., SEZER M. T., KARAOĞUZ H., DİNÇOL D., GÜNEL N., et al.

Türk Hematoloji Onkoloji Dergisi , vol.3, no.3, pp.133-137, 1993 (Peer-Reviewed Journal) Sustainable Development

83. Yeni bir tümör belirleyicisi: TPS (Doku Polipeptid Spesifik Antijeni: TPA -M3 Epitopu)

ÜNER A., SEZER M. T.

Türkiye Klinikleri Tıp Bilimleri Dergisi , vol.13, no.2, pp.156-163, 1993 (Peer-Reviewed Journal)

84. cisplatin based combination chemotherapy in metastatic testicular germ cell tumors

GÜNEL N., KARAOĞUZ H., İÇLİ F., DİNÇOL D., DEMİRKAZIK A., ÜNER A.

journal of ankara medical school , vol.14, no.2, pp.175-184, 1992 (Peer-Reviewed Journal)

85. Bir olgu nedeniyle multiple primer malign neoplazmlar

SEZGİN O., DEMİRKAZIK A., ÜNER A.

Acta Oncologica Turcica , vol.25, pp.85-90, 1992 (TRDizin)

86. Kanser hastalarında infeksiyon ataklarının, infeksiyon düşündüren dönemlerin ve mikrobiyal kolonizasyonların değerlendirilmesi

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A., et al.

Türk Hematoloji Onkoloji Dergisi , vol.2, no.3, pp.162-168, 1992 (Peer-Reviewed Journal) Sustainable Development

87. Diabetik nefropatinin erken tanısında mikroalbüminüri ve transferrinürinin önemi.

ÜNER A., YILMAZ N., YALÇIN S.

Ulusal Endokrinoloji Dergisi , vol.1, no.1, pp.11-16, 1991 (Peer-Reviewed Journal) Sustainable Development

88. Diabetik otonom nöropatiler.

MÜFTÜOĞLU O., ÜNER A., KAYSERİLİ B., PAMİR G.

Ankara Numune Hastanesi Bülteni , vol.28, pp.11-16, 1988 (Peer-Reviewed Journal) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 42

1. Mortality within 30 days after last dose of intravenous systemic anti-cancer therapy: Single-center, one-year, retrospective analysis

ÇETİN T. E., SÜTCÜOĞLU O., ÜNER A., GÜNEL N., SAVAŞ G., ÖZDEMİR N., et al.

ESMO Congress 2023, Madrid, Spain, 20 - 24 October 2023, (Summary Text)

2. Prognostic importance of GRIM score on sorafenib side effects, hospitalization and survival in hepatocellular cancer patients

Uzundal D., YAZICI O., ULAŞ KAHYA B., ÜNER A., ÖZET A., ÖZDEMİR N.

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023, (Summary Text)

3. The ability of the LACE index to predict 30-day readmissions in oncology patients

ULAŞ KAHYA B., YAZICI O., Sutcuoglu O., ÖZDEMİR N., Gunel N., ÜNER A., et al.

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023, (Summary Text)

4. SISTEMIK ANTI-KANSER TEDAVISINDEN SONRA 30 GÜNLÜK ÖLÜM ORANI, TEK MERKEZ RETROSPEKTIF ANALIZI

ÇETİN T. E., SÜTCÜOĞLU O., ÜNER A., GÜNEL N., SAVAŞ G., ÖZET A., et al.

10. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 26 - 30 April 2023, (Summary Text)

5. LOKAL İLERİ REKTUM KANSER TANILI HASTALARDA İMMÜNSKOR CD73 EKSPRESYONU VE 53BP1 EKSPRESYONUNUN NEOADJUVAN KEMORADYOTERAPİ ETKİNLİĞİ İLE İLİŞKİSİ

SÜTCÜOĞLU O., İNAN M. A., ÜNER A., SAVAŞ G., BORA H., ÖZET A., et al.

III. Ankara Hematoloji ve Onkoloji Günleri, Ankara, Turkey, 3 - 05 February 2023, (Summary Text)

6. KASTRASYONA DİRENÇLİ PROSTAT KANSERİNDE VÜCUT KİTLE İNDEKSİNİN YENİ ANTİ-ANDROJEN TEDAVİLERİNİN TEDAVİ SONUÇLARINA ETKİSİ

Sütcüoğlu O., Yazıcı O., Özdemir N., Üner A., Özet A.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text) Sustainable Development

7. İLERİ EVRE PANKREAS KANSERİNDE FOLFIRİNOX BAŞARISIZLIĞI SONRASI GEMSİTABİNE BAZLI TEDAVİLERİN ETKİNLİĞİ

Sütcüoğlu O., Yılamz F., Aktürk Esen S., Erol C., Eraslan E., Üner A., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text) Sustainable Development

8. SARKOPENİ VE OBEZİTENİN METASTATİK RCC HASTALARINDA İMMÜNOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİ ÖNGÖRMEDEKİ ROLÜ,

Aslan V., Sütcüoğlu O., Ünsal O., Yazıcı O., Özdemir N., Üner A., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

9. TIBBİ ONKOLOJI SERVİS YATIŞ SÜRESİNİ ÖNGÖRMEDE HEMOGLOBİN, ALBÜMİN, LENFOSİT VE TROMBOSİT KOMBİNASYONUNUN DEĞERİ

Sütcüoğlu O., Ünsal O., Aslan V., Ulaş Kahya B., Tahtacı G., Özdemir N., et al.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

10. Predictive Ability of The G8 Screening Test to Determine Probable Sarcopenia and Abnormal Comprehensive Geriatric Assessment in Older Patients with Solid Malignancies

ÇAVUŞOĞLU Ç., TAHTACI G., TUNA DOĞRUL R., İLERİ İ., YILDIRIM BORAZAN F., CANDEMİR B., et al.

ESPEN 2021 Virtual Congress, Cenevre, Switzerland, 9 - 14 September 2021, pp.723, (Summary Text)

11. RETROSPECTIVE ANALYSIS OF SORAFENIBTREATMENT IN ADVANCED-STAGEHEPATOCELLULAR CARCINOMA: A SINGLECENTER EXPERIENCE

ÜNSAL O., ASLAN V., YAZICI O., ÜNER A., ÖZET A., ÖZDEMİR N.

10.IGICC, 02 December 2020 - 06 December 2002, (Summary Text)

12. Primeri Bilinmeyen, Alfa-Fetoprotein (afp) Salgılayan Az Diferansiye Adeno Karsinom: Olgu Sunumu

KURT İNCİ B., GÜRLER F., YAZICI O., ÜNER A.

23. Ulusal Kanser Kongresi, Antalya, Turkey, 17 April 2019, (Summary Text)

13. Metastatik Prostat Kanserli (Mpk) Hastalarda 68Ga-Psma-Pet Metabolik Tümör Volumü(Mtv)’Nün ve Maximum Standardize Uptake Değeri (Suvmax)’Nin Prognostik Rolü

KURT İNCİ B., AYDOS U., GÜRLER F., AKDEMİR Ü. Ö., BİR YÜCEL K., GÜLBAHAR ATEŞ S., et al.

23. Ulusal Kanser Kongresi, Antalya, Turkey, 17 April 2019, (Summary Text)

14. ONKOLOJI SERVISINDE 5HT-3 ANTAGONIST İLIŞKILIİLAÇ- İLAÇ ETKILEŞIMLERI

YURTAL Ö., FAKIOĞLU D. M., ALBAYRAK A., ÖZGER H. S., ÜNER A.

ULUSAL 23.KANSER KONGRESİ, Antalya, Turkey, 17 - 21 April 2019, (Full Text)

15. ileri evre kolorektal kanserde RAS mutasyon durumu ve tümör lokalizasyonunun PET-BT 18F-FDG tutulumu ile ilişkisi

KURT İNCİ B., gürler F., YILMAZ M., TAHTACI G., YAZICI O., ÜNER A., et al.

2. ulusal immunoterapi ve onkoloji kongresi, Turkey, 31 October - 04 November 2018, (Full Text) Sustainable Development

16. A Case Study of Testicular Seminoma ExpressingSNPs and Mutations in PDGFRA, ESR1 and OtherGenes: NGS Strategies in Liquid-biopsy

Bağrıaçık E. Ü., Üner A., Atak Yücel A., Tahtacı G., Gürler F., Yaman M.

IMMUNO-ONCOLOGY WORLD CONGRESS, Vienna, Austria, 25 - 26 June 2018, pp.57, (Summary Text)

17. LOKAL İLERI AKCIĞER KANSERINDE TÜMÖR HÜCRELERININ PD-L1 POZITIFLIĞI, SAĞKALIM ÜZERINDE İYI PROGNOSTIK ETKISI VARDIR

KARACA M., TURAL D., AKAR E., OKAY D., ÇİL İ., AKYÜREK N., et al.

7.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text) Sustainable Development

18. Lokal İleri Akciğer Kanserinde Tümör Hücrelerinin PDL1 Pozitifliği Sağkalım Üzerinde İyi Prognostik Etkisi Vardır.

KARACA M., TURAL D., okay d., AKYÜREK N., ÜNER A., ÖZET A.

7.Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018, (Summary Text) Sustainable Development

19. NGS analysis for PDGFRA and ESR1 mutations in a case with testicular seminoma case

ATAK YÜCEL A., ÜNER A., BAĞRIAÇIK E. Ü., KARAKUŞ R., SAVAŞ G., KURT İNCİ B., et al.

Cell-Weizmann Institute of Science Symposium: Next Gen Immunology 2018, Rekhovot, Israel, 11 - 14 February 2018, (Summary Text)

20. NGS analysis for PDGFRA and ESR1 mutations in a case with testicular seminoma case.

ATAK YÜCEL A., ÜNER A., BAĞRIAÇIK E. Ü., KARAKUŞ R.

Cell-Weizmann Institute of Science, Next Gen Immunology, 11 - 14 February 2018, (Summary Text)

21. NGS analysis of PDGFRA ans ESR1 mutations in a case with testicular seminoma case

ATAK YÜCEL A., ÜNER A., BAĞRIAÇIK E. Ü., KARAKUŞ R., TAHTACI G., KURT İNCİ B., et al.

Cell-Weizman Institute of Science Symposium- Next Gen Immunology, Rekhovot, Israel, 11 - 14 February 2018, (Summary Text)

22. Gemsitabine Bağlı Ciddi Periferik Odem

AKSAN S., BİLGETEKİN İ., KARACA M., ÜNER A., ÖZET A., GÜNEL N.

22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)

23. Glioblastoma Multiforme Tanılı Hastalarda Notrofil/Lenfosit Oranının Prognoza Etksinin Değerlendirilmesi

DEMİR H., tufan g., GÜNAYDIN Y., ŞAHİNLİ H., KARACA M., BİLGETEKİN İ., et al.

22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)

24. Yaşlı Mide Kanserli Hastalarda Verilen Adjuvan Kemoterapinin Etkinliği

KARACA M., TURAL D., BİLGETEKİN İ., GÜLEÇ A., ÜNER A., ÖZET A.

22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text) Sustainable Development

25. D2 Disseksiyon Sonrası N3 Hastalığı Olan Mide Kanserli Hastalarda Tedavi Ne olmalıdır: Kemoterapi mi yoksa Kemoradyoterapi mi?

ÇETİN B., Bilgetekin İ., RAKICI S., Karaca F., ÖZET A., ÜNER A.

22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, vol.1, (Summary Text) Sustainable Development

26. Carcinoma of the fallopian tube presenting as axillary palpable mass

GÜLER İ., ONAN M. A., GÜNER H., HATİPOĞLU A. O., TAŞKIRAN Ç., ÜNER A.

8th International Meeting of the European Society of Gynaecological Oncology (ESGO), 19 - 22 October 2013, vol.23

27. Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.

İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., et al.

Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, 15 July 2005, (Summary Text) Sustainable Development

28. A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.

YALÇIN B., ÜNER A., AKBULUT H., İÇLİ F., IŞIKDOĞAN A., BÜYÜKÇELİK A., et al.

Proceedings of European Society of Clinical Oncology, 18 - 22 October 2002, (Summary Text) Sustainable Development

29. Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group

İÇLİ F., AKBULUT H., ÜNER A., YALÇIN B., ALTINBAŞ M., BALTALI E., et al.

Proceedings of European Society of Clinical Oncology, 18 - 22 October 2002, (Summary Text) Sustainable Development

30. Soluble E-Selectin Levels in Patients with Colorectal Cancer

AKÇALI Z., ÜNER A., GÜNEL N., YAMAÇ D., YILDIRIM E.

Proceedings of American Society of Clinical Oncology, 20 - 23 May 2000, (Summary Text) Sustainable Development

31. Four Cycles of Adjuvant AC (Adriamycin Cyclophosphamide) ± 2 Cycles of EP (Etoposide Cisplatin) in Node Positive Patients with Breast Cancer (A Randomized Trial).

İÇLİ F., AKBULUT H., DİNÇOL D., ONUR H., DEMİRKAZIK A., ÇAM R., et al.

Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999, (Summary Text) Sustainable Development

32. Mutation Analysis of BRCA1 and BRCA2 in Turkish Cancer Families: a Novel Mutation BRCA2 3414del4 Found in Male Breast Cancer.

BALCI A., huusko p., paakkönen k., Launonen v., ÜNER A., EKMEKÇİ A., et al.

Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999, (Summary Text) Sustainable Development

33. Cisplatin Plus Vinorelbine as a Salvage Regimen in Refractory Breast Cancer.

GÜNEL N., AKÇALI Z., ÜNER A., YAMAÇ D., TÖRÜNER F. S., COŞKUN U.

Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999, (Summary Text) Sustainable Development

34. Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors.

GÜNEL N., ÜNER A., NAHİDE K., YAMAÇ D., AKÇALI Z.

21st Congress of the European Society for Medical Oncology, 1 - 05 November 1996, (Summary Text)

35. Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors. Monduzzi Editore (International Proceedings Division),

GÜNEL N., ÜNER A., YAMAÇ D., AKÇALI Z.

10th Mediterranean Congress of Chemotherapy, 20 - 25 October 1996, (Summary Text)

36. 20 Yaş üzeri kadınların meme kanserine yönelik bilgi ve davranış biçimleri.

GÜNEL N., ÖZTAŞ D., ÜNER A., YAMAÇ D., ÇİFTLİK E. E.

V. Ulusal Halk Sağlığı Kongresi, Turkey, 12 - 16 October 1996, (Summary Text) Sustainable Development

37. Scintimammography with Tc-99m MDP in breast cancer.

KİTAPÇI M. T., ÜNER A., ATASEVER T., İNANIR S., GÖKÇORA N., GÜNEL N., et al.

6th Asia Oceania Congress of Nuclear Medicine and Biology, 30 September - 04 October 1996, (Summary Text) Sustainable Development

38. A phase II study of cisplatin (P) and DTIC for metastatic colorectal carcinoma resistant to 5- Fluorouracil (5-FU).

İÇLİ F., ÇAY ŞENLER F., DİNÇOL D., ARICAN A., KARAOĞUZ H., GÜNEL N., et al.

Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994, (Summary Text)

39. MINE-BOP in refractory or relapsed Non - Hodgkin’s lymphomas (NHL)

DİNÇOL D., İÇLİ F., ARICAN A., GÜNEL N., KARAOĞUZ H., DEMİRKAZIK A., et al.

Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994, (Summary Text)

40. A phase II study of Ifosfamide in unresectable diffuse malignant mesothelioma (MM)

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.

Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993, (Summary Text)

41. Comparison of EAP and FAM combination chemotherapies in advanced gastric cancer

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.

Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993, (Summary Text) Sustainable Development

42. The evaluation of infectious episodes and bacterial colonization in the cancer patients

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A.

5 th International Congress for Infectious Diseases, 7 - 11 June 1992, (Summary Text) Sustainable Development

Books 10

Metrics

Publication

146

Publication (WoS)

Publication (Scopus)

Citation (WoS)

396

H-Index (WoS)

Citation (Scopus)

424

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING

SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)